Solstein Capital’s GSK GSK Stock Holding History

Solstein Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,450	Closed	-$79K	–	370
2022 Q1	$79K	Hold	1,450	–	–	0.05%	163
2021 Q4	$80K	Hold	1,450	–	–	0.05%	180
2021 Q3	$69K	Buy	1,450 +1,416	+4,165%	+$71.1K	0.04%	205
2021 Q2	$2K	Buy	+34	New	+$1.63K	﹤0.01%	416
2020 Q4	–	Sell	-2,543	Closed	-$120K	–	142
2020 Q3	$120K	Hold	2,543	–	–	0.27%	82
2020 Q2	$130K	Hold	2,543	–	–	0.31%	67
2020 Q1	$120K	Buy	+2,543	New	+$136K	0.46%	41

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Solstein Capital's GSK Position: Q2 2022 in Review

Solstein Capital sold out of GSK (GSK) in Q2 2022, closing a stake of 1,450 shares — an estimated $79K sold.

Solstein Capital first reported a position in GSK in Q1 2020 and held it in 7 quarters. The position peaked at $130K in Q2 2020. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Solstein Capital reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
Solstein Capital sold 1,450 GSK shares in Q2 2022, an estimated $79K.
Solstein Capital first reported a position in GSK in Q1 2020 and held it in 7 quarters.
Solstein Capital's GSK position peaked at $130K in Q2 2020.
900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Solstein Capital's 13F filing for Q2 2022, filed 9 Aug 2022.